[Translation] A randomized, double-blind trial comparing the effect of dulaglutide 1.5 mg in combination with placebo on glycemic control in Chinese patients with type 2 diabetes receiving titrated basal insulin
H9X-MC-GBGO(GBGO)研究的目的是,在接受滴定基础甘精胰岛素(伴二甲
双胍和/或阿卡波糖)治疗的中国成人2 型糖尿病(T2D)患者中,评估联合使用每周
一次(QW)度拉糖肽或联合使用安慰剂QW对血糖控制的有效性和安全性。
[Translation] The purpose of the H9X-MC-GBGO (GBGO) study was to treat patients receiving titrated basal insulin glargine (with dimethicone)
In Chinese adults with type 2 diabetes (T2D) treated with biguanide and/or acarbose), the combined use of weekly
Efficacy and safety of a single (QW) dose of dulaglutide or combined placebo QW on glycemic control.